Estradiol Benzoate: High-Affinity Agonist for Estrogen Receptor Alpha Research

Executive Summary: Estradiol Benzoate is a synthetic estradiol analog with high affinity (IC₅₀ 22–28 nM) for estrogen receptor alpha (ERα) in multiple species, supporting its use as a precise tool for estrogen receptor signaling research (APExBIO). The compound is insoluble in water but dissolves readily in DMSO (≥12.15 mg/mL) and ethanol (≥9.6 mg/mL). Its solid form (MW 376.49 g/mol) ensures ease of handling and reproducibility in hormone receptor binding assays. Estradiol Benzoate is validated by HPLC, MS, and NMR analyses, offering ≥98% purity for rigorous biochemical workflows. It is distributed by APExBIO for research use only, with detailed quality control and shipping protocols to preserve integrity (Vijayan et al. 2021).

Biological Rationale

Estradiol Benzoate is a synthetic analog of 17β-estradiol, the primary endogenous estrogen in mammals. Estrogen signaling is mediated primarily via estrogen receptor alpha (ERα) and beta (ERβ), which are nuclear hormone receptors regulating gene expression in reproductive, metabolic, and neurological tissues (Vijayan et al. 2021). Synthetic agonists like Estradiol Benzoate allow precise experimental modulation of ERα, facilitating studies in hormone-dependent cancers, reproductive biology, and endocrinology. Compared to endogenous estrogens, Estradiol Benzoate offers increased metabolic stability and controllable pharmacokinetics, making it ideal for in vitro and in vivo research (Estradiol Benzoate as a Cornerstone for Translational Estrogen Receptor Research). This article extends mechanistic coverage by providing detailed assay benchmarks and solubility parameters, supplementing previous discussions of translational workflows.

Mechanism of Action of Estradiol Benzoate

Estradiol Benzoate acts as a high-affinity agonist for ERα and ERβ, as well as a progestogen receptor agonist. Upon cell entry, it binds to the ligand-binding domain of ERα, triggering conformational changes that promote receptor dimerization and nuclear translocation. The ligand-receptor complex then interacts with estrogen response elements (EREs) on DNA, modulating transcription of estrogen-responsive genes (Vijayan et al. 2021). The compound's IC₅₀ for ERα binding is 22–28 nM in human, murine, and chicken models (see Estradiol Benzoate product page). This high affinity enables robust, reproducible activation of estrogen receptor-mediated signaling pathways. Estradiol Benzoate's mechanism is further characterized by its prodrug nature—the benzoate ester is hydrolyzed in vivo to 17β-estradiol, ensuring sustained receptor activation (Estradiol Benzoate: Mechanistic Precision and Strategic Value). This article clarifies the molecular specificity of receptor engagement, updating earlier strategic perspectives with new quantitative data.

Evidence & Benchmarks

• Estradiol Benzoate binds estrogen receptor alpha (ERα) with an IC₅₀ of 22–28 nM in competitive ligand binding assays (APExBIO B1941 datasheet, product page).
• It exhibits ≥98% purity as determined by HPLC, MS, and NMR analyses, supporting reproducibility in biochemical assays (APExBIO).
• The compound is insoluble in water but soluble in DMSO (≥12.15 mg/mL) and ethanol (≥9.6 mg/mL) at 25°C, facilitating preparation of concentrated stock solutions (APExBIO).
• Estradiol Benzoate is stable when stored as a solid at -20°C, but solution stability is limited; use prepared solutions within days to prevent degradation (APExBIO).
• Validated as a reference estrogen in hormone receptor binding assays and for ERα/ERβ signaling pathway studies in multiple species (Vijayan et al. 2021).

Applications, Limits & Misconceptions

Estradiol Benzoate is widely used in hormone receptor binding assays, estrogen receptor signaling research, and preclinical models of hormone-dependent cancers. It enables mechanistic studies of ERα-mediated gene regulation, investigation of endocrine disruption, and benchmarking of new ER ligands. However, its use is limited to research settings; it is not intended for diagnostic or therapeutic applications. Direct clinical application is prohibited (APExBIO).

This article extends prior coverage by enumerating experimental boundaries and highlighting pitfalls in assay design, supplementing advanced use-cases found in Estradiol Benzoate: Precision Agonist for Estrogen Receptor Research.

Common Pitfalls or Misconceptions

• Estradiol Benzoate is not water-soluble; attempts to dissolve in aqueous buffers will result in precipitation and loss of activity.
• It is not suitable for diagnostic, clinical, or veterinary use—its use is strictly limited to scientific research.
• Prolonged storage of Estradiol Benzoate solutions (even at -20°C) results in compound degradation; always prepare fresh stock solutions as needed.
• Estradiol Benzoate's progestogen receptor activity is weaker than its estrogenic activity and may not be suitable as a selective progestogen probe.
• It should not be used as a direct substitute for 17β-estradiol in all experimental contexts due to differences in hydrolysis rates and pharmacokinetics.

Workflow Integration & Parameters

Estradiol Benzoate (SKU B1941, supplied by APExBIO) is provided as a solid, facilitating accurate weighing and solution preparation. Dissolve in DMSO or ethanol to prepare stock solutions; avoid water or buffer-based solvents. For hormone receptor binding assays, typical working concentrations range from 1 nM to 1 μM, depending on assay sensitivity and receptor abundance. Solutions should be freshly prepared and used within 24–48 hours to ensure integrity. Store the solid compound at -20°C in a desiccated environment. Shipments from APExBIO use blue ice to maintain compound stability during transit. Quality control data (HPLC, MS, NMR) accompanies each lot to confirm identity and purity. For advanced workflows integrating Estradiol Benzoate in high-throughput screening or in vivo studies, refer to recent updates in Next-Generation Strategies for Estrogen Receptor Signaling Research, which this article updates with new purity and solubility data.

Conclusion & Outlook

Estradiol Benzoate remains a cornerstone tool for mechanistic and translational studies in estrogen receptor biology. Its well-characterized binding affinity, stability profile, and high purity support its adoption in rigorous hormone receptor binding assays and estrogen receptor signaling research. Ongoing advancements in assay technologies and translational models will further enhance the utility of Estradiol Benzoate, especially as research demands higher standards of reproducibility and molecular precision. APExBIO continues to support the scientific community by supplying high-quality Estradiol Benzoate (B1941) for research use, validated by comprehensive analytical data (Estradiol Benzoate product page).